about
Translation of Cardiac Myosin Activation with 2-deoxy-ATP to Treat Heart Failure via an Experimental Ribonucleotide Reductase-Based Gene Therapy2-Deoxy adenosine triphosphate improves contraction in human end-stage heart failure.An optimized and simplified system of mouse embryonic stem cell cardiac differentiation for the assessment of differentiation modifiers.AAV6-mediated Cardiac-specific Overexpression of Ribonucleotide Reductase Enhances Myocardial Contractility.A Tension-Based Model Distinguishes Hypertrophic versus Dilated Cardiomyopathy.Heart failure with preserved ejection fraction and skeletal muscle physiology.Gene Therapy for Nonischemic Cardiomyopathy: Moving Forward by Learning From Lessons of the Past.Viral-mediated gene transfer to mouse primary neural progenitor cells.Fast and sensitive HPLC-MS/MS method for direct quantification of intracellular deoxyribonucleoside triphosphates from tissue and cells.Contractile properties of developing human fetal cardiac muscle.
P50
Q33728779-C5079D28-34AB-469F-9247-E1E8963DF206Q34995668-D21A18C1-6BC2-4284-BE5B-C960EDB876C6Q35131230-4999BD1C-74C1-4E84-BFC1-4A07FB1EFD6DQ36756838-7D2E9E4B-62EF-44FF-97A2-86CB76FD3BE5Q36922076-99C40B27-802A-4926-A3FE-B381A7424B68Q38931738-DBF25F22-804B-41C3-82BE-3D03CEE49482Q45872537-CC60A537-09A3-480F-B3E5-CCCBAEBB8737Q45882544-881A17FE-323C-4FD9-A25F-F9DA83EE4C07Q47843426-C464D643-FBD2-4C33-ABFD-EBF49BB0825AQ52910400-7372E619-99FE-4AFB-87EB-456BD97E60E4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Farid Moussavi-Harami
@ast
Farid Moussavi-Harami
@en
Farid Moussavi-Harami
@es
Farid Moussavi-Harami
@nl
type
label
Farid Moussavi-Harami
@ast
Farid Moussavi-Harami
@en
Farid Moussavi-Harami
@es
Farid Moussavi-Harami
@nl
prefLabel
Farid Moussavi-Harami
@ast
Farid Moussavi-Harami
@en
Farid Moussavi-Harami
@es
Farid Moussavi-Harami
@nl
P106
P1153
6505865601
P31
P496
0000-0002-0189-7214